Imagine a world where a wide range of diseases can be detected and monitored by a simple blood test—and breakthrough treatments are developed in months, not years.
In this CNBC International interview, SandboxAQ CEO Jack Hidary shares how this vision is becoming a reality through SandboxAQ’s Quantitative AI technology. Partnering with global biopharma leader Sanofi, SandboxAQ is accelerating the discovery of disease-specific biomarkers, enabling precise, real-time insights into disease progression and diagnostics.
Learn how SandboxAQ’s Large Quantitative Models (LQMs)—trained on chemistry, biology, pharmacology, and physics—are helping Sanofi transform both diagnostics and drug development. Jack explains how a rapid, iterative process allows for faster testing and validation, reducing what once took years into just months. The goal? To dramatically improve clinical trial success rates and move biopharma beyond its current hit-or-miss model.
If you’re interested in the future of healthcare innovation and how AI is set to change lives, watch now to discover how SandboxAQ and Sanofi are revolutionizing biopharma.
Subscribe for more on AI-driven breakthroughs in healthcare.
Want to learn more? Visit: https://www.sandboxaq.com/industries/life-sciences
source